Compare, Analyse Unichem Lab with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ACTAVIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
ACTAVIS
Dec-18
UNICHEM LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs29214,247-   
Low Rs1829,557-   
Sales per share (Unadj.) Rs167.73,494.9-  
Earnings per share (Unadj.) Rs-3.6-1,125.7-  
Cash flow per share (Unadj.) Rs5.9368.3-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.314,414.7-  
Shares outstanding (eoy) m70.38332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.43.4 41.5%   
Avg P/E ratio x-65.3-10.6 617.4%  
P/CF ratio (eoy) x39.932.3 123.4%  
Price / Book Value ratio x0.60.8 77.1%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,6803,958,701 0.4%   
No. of employees `0002.616.9 15.4%   
Total wages/salary Rs m2,3930-   
Avg. sales/employee Rs Th4,535.268,780.9 6.6%   
Avg. wages/employee Rs Th919.80-   
Avg. net profit/employee Rs Th-98.2-22,154.4 0.4%   
INCOME DATA
Net Sales Rs m11,8011,162,397 1.0%  
Other income Rs m98422,229 4.4%   
Total revenues Rs m12,7851,184,626 1.1%   
Gross profit Rs m-83530,461 -2.7%  
Depreciation Rs m674496,899 0.1%   
Interest Rs m7567,077 0.1%   
Profit before tax Rs m-600-511,287 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0130,399 0.0%   
Tax Rs m-343-6,479 5.3%   
Profit after tax Rs m-256-374,409 0.1%  
Gross profit margin %-7.12.6 -270.0%  
Effective tax rate %57.31.3 4,519.4%   
Net profit margin %-2.2-32.2 6.7%  
BALANCE SHEET DATA
Current assets Rs m20,384476,754 4.3%   
Current liabilities Rs m5,029421,753 1.2%   
Net working cap to sales %130.14.7 2,750.0%  
Current ratio x4.11.1 358.6%  
Inventory Days Days10520 534.9%  
Debtors Days Days13566 203.4%  
Net fixed assets Rs m9,023131,577 6.9%   
Share capital Rs m1410-   
"Free" reserves Rs m26,0580-   
Net worth Rs m26,1994,794,344 0.5%   
Long term debt Rs m01,688,262 0.0%   
Total assets Rs m31,4967,494,650 0.4%  
Interest coverage x-7.0-6.6 105.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.40.2 241.6%   
Return on assets %-0.6-4.1 14.0%  
Return on equity %-1.0-7.8 12.5%  
Return on capital %-2.0-4.8 41.3%  
Exports to sales %69.40-   
Imports to sales %00-   
Net fx Rs m7,5920-   
CASH FLOW
From Operations Rs m-3,278415,281 -0.8%  
From Investments Rs m-2,860228,143 -1.3%  
From Financial Activity Rs m-24-712,746 0.0%  
Net Cashflow Rs m-4,690-68,977 6.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.63 Rs / USD

Compare UNICHEM LAB With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: PROCTER & GAMBLE HEALTH  BIOCON   WOCKHARDT  DISHMAN PHARMA  IPCA LABS  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

UNICHEM LAB SHARE PRICE


May 7, 2021 03:37 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON UNICHEM LAB

UNICHEM LAB - TORRENT PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS